Publications

Primary melanoma histologic subtype impacts melanoma specific survival and response to systemic therapy

Lattanzi, M., Lee, Y., Simpson, D., Moran, U., Darvishian, F., Kim, R. H., Hernando, E., Polsky, D., Hanniford, D., Shapiro, R., Berman, R., Pavlick, A. C., Wilson, M. A., Kirchhoff, T., Weber, J. S., Zhong, J., & Osman, I. (2019). Journal of the National Cancer Institute, 111(2), 180–188.

PMID: 29912415

Differential phosphorylation and N-terminal configuration of capsid subunits in parvovirus assembly and viral trafficking

Gil-Ranedo, J., Hernando, E., Valle, N., Riolobos, L., Maroto, B., & Almendral, J. M. (2018). Virology, 518, 184–194.

PMID: 29524834

miR-204-5p and miR-211-5p contribute to BRAF inhibitor resistance in melanoma

Díaz-Martínez, M., Benito-Jardón, L., Alonso, L., Koetz-Ploch, L., Hernando, E., & Teixidó, J. (2018). Cancer research, 78(4), 1017–1030.

PMID: 29229605

Lysyl oxidase-like 3 is required for melanoma cell survival by maintaining genomic stability

Santamaría, P. G., Floristán, A., Fontanals-Cirera, B., Vázquez-Naharro, A., Santos, V., Morales, S., Yuste, L., Peinado, H., García-Gómez, A., Portillo, F., Hernando, E., & Cano, A. (2018). Cell death and differentiation, 25(5), 935–950.

PMID: 29229995

Harnessing BET inhibitor sensitivity reveals AMIGO2 as a melanoma survival gene

Fontanals-Cirera, B., Hasson, D., Vardabasso, C., Di Micco, R., Agrawal, P., Chowdhury, A., Gantz, M., de Pablos-Aragoneses, A., Morgenstern, A., Wu, P., Filipescu, D., Valle-Garcia, D., Darvishian, F., Roe, J. S., Davies, M. A., Vakoc, C. R., Hernando, E., & Bernstein, E. (2017). Molecular cell, 68(4), 731–744.e9.

PMID: 29149598

A Systems Biology Approach Identifies FUT8 as a Driver of Melanoma Metastasis

Agrawal, P., Fontanals-Cirera, B., Sokolova, E., Jacob, S., Vaiana, C. A., Argibay, D., Davalos, V., McDermott, M., Nayak, S., Darvishian, F., Castillo, M., Ueberheide, B., Osman, I., Fenyö, D., Mahal, L. K., & Hernando, E. (2017). Cancer cell, 31(6), 804–819.e7.

PMID: 28609658

Krüppel-like factor 4 (KLF4) regulates the miR-183~96~182 cluster under physiologic and pathologic conditions

Segura, M. F., Jubierre, L., Li, S., Soriano, A., Koetz, L., Gaziel-Sovran, A., Masanas, M., Kleffman, K., Dankert, J. F., Walsh, M. J., & Hernando, E. (2017). Oncotarget, 8(16), 26298–26311.

PMID: 28412746

TGFβ-miR-182-BRCA1 axis controls the mammary differentiation hierarchy

Martinez-Ruiz, H., Illa-Bochaca, I., Omene, C., Hanniford, D., Liu, Q., Hernando, E., & Barcellos-Hoff, M. H. (2016). Science signaling, 9(457), ra118.

PMID: 27923913

MicroRNA-125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway

Koetz-Ploch, L., Hanniford, D., Dolgalev, I., Sokolova, E., Zhong, J., Díaz-Martínez, M., Bernstein, E., Darvishian, F., Flaherty, K. T., Chapman, P. B., Tawbi, H., & Hernando, E. (2017). Pigment cell & melanoma research, 30(3), 328–338.

PMID: 28140520

BET and BRAF inhibitors act synergistically against BRAF mutant melanoma

Paoluzzi, L., Hanniford, D., Sokolova, E., Osman, I., Darvishian, F., Wang, J., Bradner, J. E., & Hernando, E. (2016). Cancer medicine, 5(6), 1183–1193.

PMID: 27169980